GA-ASI Completes Full-Scale Fatigue Test on MQ-9B for Second Lifetime

Share

SAN DIEGO, CA / ACCESSWIRE / October 14, 2024 / On Sept. 30, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed a major milestone with the full-scale fatigue testing of an MQ-9B Remotely Piloted Aircraft (RPA). The team completed the "second lifetime" of fatigue testing, which is equivalent to 80,000 operating hours and represents an important step in validating the design of the airframe system. The testing is part of the aircraft certification to NATO standard STANAG 4671, where the aircraft will ultimately be tested through three lifetimes, thereby proving the 40,000-hour lifetime of the airframe.

The full-scale fatigue test simulates the aircraft's design service through the application of repeated structural loading on the assembled airframe. The testing identifies any potential structural deficiencies ahead of fleet usage and assists in developing inspection and maintenance schedules for the airframe. The results of the test will be used as part of the documentation for certification and will form the basis for in-service inspections of structural components.

MQ-9B is GA-ASI's most advanced RPA and includes the SkyGuardian® and SeaGuardian® models as well as the new Protector RG Mk1 that is currently being delivered to the United Kingdom Royal Air Force (RAF).

"Full-scale fatigue testing is an integral part of validating the airframe design and a key input for the certification of the airframe prior to entering service," said Chris Dusseault, vice president of MQ-9B in Europe. "The completion of the fatigue test builds confidence for our MQ-9B customers that the SkyGuardian/SeaGuardian meets the stringent design rigor and is mature at Entry into Service."

The testing is the validation of years of design and analysis efforts. This is the second of three lifetimes of testing for the airframe. Two of the lifetimes simulate the operation of an aircraft under normal conditions, and the third has intentional damage inflicted on the airframe's critical components to demonstrate its resistance to operational damage that may occur over the lifetime of the air vehicle.

Testing was conducted from Jan. 31, 2024, through Sept. 30, 2024, at Wichita State University's National Institute for Aviation Research in Wichita, Kansas. The airframe tested is a production airframe purpose-built to support the test campaign.

In addition to the RAF, contracts have been signed for MQ-9B with Belgium, Canada, Japan, Taiwan and the U.S. Air Force in support of the Special Operations Command. The Japan Coast Guard is currently operating the SeaGuardian for maritime operations, and the Japan Maritime Self-Defense Force (JMSDF) selected SeaGuardian for its Medium-Altitude, Long-Endurance (MALE) RPA System Trial Operation Project.

About GA-ASI

General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable RPA systems, radars, and electro-optic and related mission systems, including the Predator® RPA series and the Lynx® Multi-mode Radar. With more than eight million flight hours, GA-ASI provides long-endurance, mission-capable aircraft with integrated sensor and data link systems required to deliver persistent situational awareness. The company also produces a variety of sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas.

For more information, visit www.ga-asi.com.

Avenger, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are registered trademarks of General Atomics Aeronautical Systems, Inc.

Contact Information

GA-ASI Media Relations
asi-mediarelations@ga-asi.com

SOURCE: General Atomics Aeronautical Systems, Inc.

View the original press release on newswire.com.

General Atomics

Subscribe to releases from ACCESSWIRE

Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESSWIRE

Participation in the Multilateral System Remains High as Performance Drops, New Index Finds17.10.2024 13:00:00 EEST | Press release

The Multilateralism Index 2024 reveals a contradiction: while participation in the multilateral system has largely held steady or even increased, its effectiveness in addressing global challenges has declined. WASHINGTON, DC / ACCESSWIRE / October 17, 2024 / Today marks the launch of the second edition of the Multilateralism Index from the International Peace Institute (IPI) and the Institute for Economics & Peace (IEP). The Index reveals that states remain engaged in the global multilateral system even as it increasingly struggles to address the crises it faces.Multilateralism Index 2024 Report An image of the front cover of the Multilateralism Index 2024 Report Key results The performance of the multilateral system declined across all five domains examined. Peace and security showed the steepest deterioration in performance, with the number of armed conflicts rising from 39 in 2013 to 55 in 2022. Climate action and human rights also saw significant declines in performance, despite in

Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells16.10.2024 09:00:00 EEST | Press release

ATH-063 significantly increased the number of circulating regulatory T cells (Tregs) across all doses and demonstrated enrichment in six well-described genes related to induced Treg anti-inflammatory activities No serious adverse effects or dose limiting toxicities were observed at any dose level, and ATH-063 demonstrated favorable pharmacokinetics (PK) The data provides clinical verification for Athos' Proprietary AI2 (Artificial Intelligence for Autoimmune drug development) computational software platform which generated ATH-063 LOS ANGELES, CA / ACCESSWIRE / October 16, 2024 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, today announced topline results for the company's Phase 1 clinical trial of ATH-063, an investigational oral small molecule G9A inhibitor and the company's lead asset in development for the treatment of inflammatory bowel dise

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History16.10.2024 06:00:00 EEST | Press release

LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively. Access the official USDA-APHIS publication here. "With USDA approval for our GE pea, Moolec has now secured regulatory clearance for all of our key crops in the US: safflower, soybean, and pea," said Gastón Paladini, CEO and Co-Founder of Moolec. "We are proud to be the only Molecular Farming company with three US regulatory approvals and a major commercial contract. This milestone

Transoft Solutions Acquires Advanced Mobility Analytics Group (AMAG)15.10.2024 09:00:00 EEST | Press release

Expands Transportation Safety and Operations Portfolio VANCOUVER, BC / ACCESSWIRE / October 15, 2024 / Transoft Solutions Inc. ("Transoft") - a global leader in transportation engineering, analysis, and operations software - announced today that it has acquired Advanced Mobility Analytics Group Pty Ltd ("AMAG"), a leading developer of video-based analytics software to facilitate improved traffic safety and management of road infrastructure, headquartered in Brisbane, Australia. Transoft Solutions Acquires AMAG The secure cloud-based SMART platform developed by AMAG supports Vision Zero and Safe Systems approaches globally. Using computer vision, big data analytics, and advanced econometrics, its predictive analytics help organizations to create a safer and better managed road infrastructure. "We are delighted to welcome AMAG's employees to Transoft," said Daniel Shihundu, P.Eng., CEO at Transoft. "We feel there is an excellent cultural fit, and combining our talented teams will acceler

New GASA Report Estimates $688 Billion in Scam Losses Across Asia Amid Rising Cyberthreat Worldwide14.10.2024 21:00:00 EEST | Press release

2024 Asia Scam Report Reveals Singapore and Japan See Decline in Scam Losses SINGAPORE / ACCESSWIRE / October 14, 2024 / The Global Anti-Scam Alliance (GASA) has released the highly anticipated 2024 Asia Scam Report. Based on survey responses from 24,731 consumers across Asia, this annual report offers insights into the growing threat posed by scammers and their increasingly sophisticated tactics.GASA's Asia Scam Report 2024 Individual survey responses were extrapolated to report an estimated total loss of $688.42 billion over the last 12 months, a figure that represents a significant portion of the estimated $1.026 trillion global scam losses reported in GASA's 2023 data. This year's report highlights key trends such as the rise of AI-generated scam messages and the surge in social media-related fraud. Key Findings from the 2024 Asia Scam Report: Rapid Revictimization: Scam victims across Asia tend to be scammed repeatedly after they have been successfully targeted once. Singapore (-4

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye